Marie Roskrow

Dr. Roskrow has a background in hematology and oncology and is a senior executive with international experience in the healthcare and financial sectors. She has extensive experience from both early and later-stage clinical development of novel anti-cancer compounds, including therapeutic cancer vaccines, and she has earned several awards and honors for her research work.

In addition to senior clinical and research positions, Dr. Roskrow has extensive experience as an investment banker, CEO and chairperson in both private and listed companies, including the GSF Research Institute (Munich), Patrys Ltd (Melbourne), Imevax (Munich) and Lazard Healthcare Investment Banker (New York, San Francisco, Sydney).

Dr. Roskrow has been involved in executing public and private biotechnology and pharmaceutical merger and acquisition deals, product in/out-licensing deals and financing rounds. In addition, Dr. Roskrow has an extensive network of relationships with executives and board members of pharmaceutical and biotechnology companies and leading clinical centers. She holds BSc (Hons), MBBS (Hons) and a PhD in Immunology, from the University of London.